These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 14658416)

  • 41. Nicorandil prevents microvascular dysfunction resulting from PCI in patients with stable angina pectoris: a randomised study.
    Hirohata A; Yamamoto K; Hirose E; Kobayashi Y; Takafuji H; Sano F; Matsumoto K; Ohara M; Yoshioka R; Takinami H; Ohe T
    EuroIntervention; 2014 Jan; 9(9):1050-6. PubMed ID: 24457276
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nicorandil and Long-acting Nitrates: Vasodilator Therapies for the Management of Chronic Stable Angina Pectoris.
    Tarkin JM; Kaski JC
    Eur Cardiol; 2018 Aug; 13(1):23-28. PubMed ID: 30310466
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Potassium channel activators in vasospastic angina.
    Lablanche JM; Bauters C; McFadden EP; Quandalle P; Bertrand ME
    Eur Heart J; 1993 Jul; 14 Suppl B():22-4. PubMed ID: 8370368
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardioprotection by opening of the K(ATP) channel in unstable angina. Is this a clinical manifestation of myocardial preconditioning? Results of a randomized study with nicorandil. CESAR 2 investigation. Clinical European studies in angina and revascularization.
    Patel DJ; Purcell HJ; Fox KM
    Eur Heart J; 1999 Jan; 20(1):51-7. PubMed ID: 10075141
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cardioprotective and Antianginal Efficacy of Nicorandil: A Comprehensive Review.
    Goel H; Carey M; Elshaikh A; Krinock M; Goyal D; Nadar SK
    J Cardiovasc Pharmacol; 2023 Aug; 82(2):69-85. PubMed ID: 37256547
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term use of oral nicorandil stabilizes coronary plaque in patients with stable angina pectoris.
    Izumiya Y; Kojima S; Kojima S; Araki S; Usuku H; Matsubara J; Sakamoto K; Tsujita K; Nagayoshi Y; Kaikita K; Sugiyama S; Ogawa H
    Atherosclerosis; 2011 Feb; 214(2):415-21. PubMed ID: 21168844
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potassium channel openers in myocardial ischaemia: therapeutic potential of nicorandil.
    Gomma AH; Purcell HJ; Fox KM
    Drugs; 2001; 61(12):1705-10. PubMed ID: 11693460
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of intravenous nicorandil and preexisting angina pectoris on short- and long-term outcomes in patients with a first ST-segment elevation acute myocardial infarction.
    Ishii H; Ichimiya S; Kanashiro M; Amano T; Ogawa Y; Mitsuhashi H; Sakai S; Uetani T; Murakami R; Naruse K; Murohara T; Matsubara T
    Am J Cardiol; 2007 May; 99(9):1203-7. PubMed ID: 17478142
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Influence of the Potassium Channels Activator Nicorandil to the Quality of Life in Patients With Ishemic Heart Disease and Stable Angina Pectoris].
    Sizova ZM; Zakharova VL; Kozlova NV; Kuchkina TS
    Kardiologiia; 2016 Jun; 56(6):26-31. PubMed ID: 28290843
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Trimetazidine. A review of its use in stable angina pectoris and other coronary conditions.
    McClellan KJ; Plosker GL
    Drugs; 1999 Jul; 58(1):143-57. PubMed ID: 10439934
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical profile of nicorandil: an overview of its hemodynamic properties and therapeutic efficacy.
    Krumenacker M; Roland E
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S93-102. PubMed ID: 1282184
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of Angina: Where Are We?
    Balla C; Pavasini R; Ferrari R
    Cardiology; 2018; 140(1):52-67. PubMed ID: 29874661
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacologic management of chronic stable angina.
    Dixit D; Kimborowicz K
    JAAPA; 2015 Jun; 28(6):. PubMed ID: 25989429
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nicorandil enhances myocardial tolerance to ischemia without progressive collateral recruitment during coronary angioplasty.
    Sakai K; Yamagata T; Teragawa H; Matsuura H; Chayama K
    Circ J; 2002 Apr; 66(4):317-22. PubMed ID: 11954943
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect on periprocedural myocardial infarction of intra-coronary nicorandil prior to percutaneous coronary intervention in stable and unstable angina.
    Hwang J; Lee HC; Kim BW; Yang MJ; Park JS; Park JH; Lee HW; Oh J; Choi JH; Cha KS; Hong TJ; Song S; Kim SP
    J Cardiol; 2013 Aug; 62(2):77-81. PubMed ID: 23731922
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of nicorandil and atenolol in stable angina pectoris.
    Hughes LO; Rose EL; Lahiri A; Raftery EB
    Am J Cardiol; 1990 Sep; 66(7):679-82. PubMed ID: 2144705
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term administration of nicorandil abolishes ischemic and pharmacologic preconditioning of the human myocardium: role of mitochondrial adenosine triphosphate-dependent potassium channels.
    Loubani M; Galiñanes M
    J Thorac Cardiovasc Surg; 2002 Oct; 124(4):750-7. PubMed ID: 12324733
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Angina and Its Management.
    Kloner RA; Chaitman B
    J Cardiovasc Pharmacol Ther; 2017 May; 22(3):199-209. PubMed ID: 28196437
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effectiveness of low dose denopamine, a beta1-adrenoceptor agonist, in a patient with vasospastic angina refractory to intensive medical treatment.
    Nakajima D; Negoro N; Nakaboh A; Nakakoji T; Hoshiga M; Nariyama J; Ishihara T; Hanafusa T
    Int J Cardiol; 2006 Apr; 108(2):281-3. PubMed ID: 15913812
    [No Abstract]   [Full Text] [Related]  

  • 60. [Characteristics of angina pectoris therapy with nitrates].
    Silber S
    Herz; 1996 Jun; 21 Suppl 1():4-22. PubMed ID: 8767920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.